Skip to Main Content

OSHA Clarifies Position on Workplace Safety Incentive Programs, Post-Incident Drug Testing Under New Reporting Regulations

Prepared for the Katten Safety Advisory Group
Advisory | October 16, 2018

The Occupational Safety and Health Administration ("OSHA") issued a memorandum, on October 11, 2018, clarifying its position on the permissibility of safety incentive programs and post-incident drug testing. The memorandum supplements OSHA's 2016 rule prohibiting retaliation against employees reporting work-related injuries or illnesses (29 C.F.R. § 1904.35(b)(1)(iv)).

Full access to Katten Safety Advisory Group alerts is restricted to members. For more information on KSAG, please click here. If you are interested in membership in KSAG, please email

Katten Websites   Careers  |  Alumni  |  Mobile Site
Contact Us   Offices  |  Media Center  |  People  |  Email
Legal Notices   Disclaimer  |  Privacy Notice  |  Cookie Notice  |  United Kingdom Notices  | Accessibility 
Attorney Advertisting. © 2019 Katten Muchin Rosenman LLP